Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: Implications for individualized chemotherapy and new drug screening programs-Reference-Cited by-同舟云学术

Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: Implications for individualized chemotherapy and new drug screening programs

Published:1992-01 Issue:6 Volume:10 Page:359-368
ISSN:0737-1454
Container-title:The International Journal of Cell Cloning
language:en
Short-container-title:The International Journal of Cell Cloning

Author:

Parchment Ralph E.¹,Soleimanpour Kaveh¹,Petrose Susan¹,Murphy Martin J.¹

Affiliation:

1. Hippie Cancer Research Center, Dayton, Ohio, USA

Publisher

Wiley

Subject

Cell Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/stem.5530100608

Reference20 articles.

1. He's Not Going to Talk About In Vitro Predictive Assays Again, Is He?

2. Highly Specific Prediction of Antineoplastic Drug Resistance With an In Vitro Assay Using Suprapharmacologic Drug Exposures

3. selection of Cancer Chemotherapy for a Patient by an In Vitro Assay Versus a Clinician

4. The human tumor cloning assay in cancer research and therapy: A review with clinical correlations

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: Implications for diagnostic microdosing;International Journal of Cancer;2014-02-20

2. Cross-resistance to photofrin-mediated photodynamic therapy and UV light and recovery from photodynamic therapy damage in Rif-8A mouse fibrosarcoma cells measured using viral capacity;Journal of Photochemistry and Photobiology B: Biology;1997-04

3. Automated imaging and quantitation of tumor cells and CFU-GM colonies in microcapillary cultures: toward therapeutic index-based drug screening;Investigational New Drugs;1995-12

4. Reduced topoisomerase II activity in multidrug-resistant human non-small cell lung cancer cell lines;British Journal of Cancer;1995-01

5. Perspectives;Alternative Mechanisms of Multidrug Resistance in Cancer;1995